RE: RE: Time to act Chief...Bioniche is still a Biotech, even if it is valued like one of the dregs of a dying Rust Belt industry.
To say that AH is the only asset of "real value" lets McRae and Company off the hook for absolutely failing shareholders in having his other assets properly recognized by the market.
Today, as in right this second, Bioniche the "biotech" is trading at exactly 1 year's revenue. That is a disaster in itself, but to top it off the "biotech" trading at 1 year's revenue has a fully completed, FDA validated P3 cancer trial under its belt. Is there another "biotech", anywhere on any exchange, with a successful P3 cancer drug, valued equally or less? What about one with 35 mil in rev and a successful P3 cancer drug valued at 1 year's revenue?...anyone know of anything?
If nothing else, McRae should walk the plank for that alone. Who would tolerate this valuation, for this length of time?
I started to feel a bit sorry for the current regime, given their time in office and all the things that they have almost, but never quite accomplished. Fortunately, I have snapped out of it.